Clinical Trial Update: Selinexol Combined With Dexamethasone in the Treatment of CAEBV [Phase 3]

View source ↗

Summary

Phase 3 trial update for Selinexol combined with Dexamethasone in chronic active Epstein-Barr virus infection (CAEBV) is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Epstein-barr Virus Infection

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Selinexol (Selinexor)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: CAEBV | Phase 3 | Status: UNKNOWN